Home / BVAXF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does BVAXF make money? Does BVAXF have pricing power? What's the Earnings Whisper? Will BVAXF profit more as the business scales? What is BVAXF's management track record? Is BVAXF's current price justified?

BioVaxys Technology Corp.

$0.08 -$0.09 (-50.95%)

OTC · 14 Sep 2026 18:18 UTC

Previous Close

$0.1

Day Range

$0.07$0.08

Year Range

$0.02$0.23

Market Cap

2.45M

AVG Volume

35.21K

Trailing/Forward PE

-0.91/-

PEG ratio

0.04

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Net Income (CAD)

BVAXF Net Income (CAD) by year
Period	Net Income (CAD)
2024	-3.95M
2023	-6.4M
2022	-11.73M
2021	-6.46M
2020	-1.17M
2019	-230.12K

Operating Income (CAD)

BVAXF Operating Income (CAD) by year
Period	Operating Income (CAD)
2024	-3.21M
2023	-5.99M
2022	-4.08M
2021	-6.44M
2020	-1.08M
2019	-229.91K

EBITDA (CAD)

BVAXF EBITDA (CAD) by year
Period	EBITDA (CAD)
2024	-3.21M
2023	-6.45M
2022	-3.2M
2021	-6.44M
2020	-1.08M
2019	-229.69K

Cash Flows (CAD)

BVAXF Cash Flows (CAD) by year
Period	Cash Flows (CAD)
2024	-1.86M
2023	-1.05M
2022	-1.57M
2021	-5.29M
2020	-1.23M
2019	-230.76K

EPS (CAD)

BVAXF EPS (CAD) by year
Period	EPS (CAD)
2024	-0.17
2023	-0.64
2022	-1.14
2021	-0.77
2020	-0.35
2019	-0.11

Expenses (CAD)

BVAXF Expenses (CAD) by year
Period	Expenses (CAD)
2024	3.12M
2023	2.69M
2022	3.99M
2021	5.98M
2020	1.04M
2019	205.85K

Cash & Debt (CAD)

BVAXF Cash & Debt (CAD) by year
Period	Cash & Debt (CAD)
2024	211.81K
2023	977
2022	141.9K
2021	593.12K
2020	2.42M
2019	228.98K

Debt ratios

BVAXF Debt ratios by year
Period	Debt ratios
2024	0.01
2023	0
2022	0.01

Return on Capital

BVAXF Return on Capital by year
Period	Return on Capital
2024	205.97%
2023	189.7%
2022	1516.09%
2021	-78.98%
2020	-12.29%
2019	-121.04%

Shares Outstanding

BVAXF Shares Outstanding by year
Period	Shares Outstanding
2024	22.01M
2023	14.52M
2022	10.59M
2021	9.15M
2020	3.68M
2019	2.11M

Book Value Per Share (CAD)

BVAXF Book Value Per Share (CAD) by year
Period	Book Value Per Share (CAD)
2024	-0.09
2023	-0.23
2022	-0.07
2021	0.89
2020	2.6
2019	0.09

Total Assets (CAD)

BVAXF Total Assets (CAD) by year
Period	Total Assets (CAD)
2024	1.3M
2023	113.48K
2022	865.56K
2021	8.5M
2020	10.46M
2019	306.26K

Free Cash Flow Yield

BVAXF Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-100.06%
Sep 26	-99.66%
Sep 26	-143.37%
Aug 26	-142.44%
Aug 26	-112.58%
Aug 26	-92.68%
Aug 26	-125.7%
Jul 26	-89.68%
Jul 26	-87.42%
Jul 26	-82.23%
Jul 26	-86.82%
Jul 26	-62.88%
Jun 26	-75.93%
Jun 26	-69.44%
Jun 26	-61.76%
Jun 26	-55.4%
May 26	-58.97%
May 26	-62.07%
May 26	-60.07%
May 26	-167.07%
May 26	-199.88%
Apr 26	-227.29%
Apr 26	-230%
Apr 26	-206.36%
Apr 26	-195.49%
Mar 26	-150.31%
Mar 26	-172.23%
Mar 26	-137.43%
Mar 26	-137.19%
Feb 26	-85.24%
Feb 26	-101.19%
Feb 26	-104.99%
Feb 26	-76.02%
Jan 26	-73.83%
Jan 26	-59.36%
Jan 26	-53.55%
Jan 26	-55.26%
Jan 26	-58.71%
Dec 25	-50.55%
Dec 25	-54.75%
Dec 25	-61.02%
Dec 25	-66.79%
Nov 25	-53.92%
Nov 25	-48.3%
Nov 25	-53.73%
Nov 25	-53.25%
Oct 25	-48.84%
Oct 25	-42.38%
Oct 25	-48.48%
Oct 25	-38.99%
Oct 25	-37.65%
Sep 25	-39.74%
Sep 25	-39.48%
Sep 25	-41.38%
Sep 25	-42.48%
Aug 25	-44.54%
Aug 25	-34.26%
Aug 25	-45.7%
Aug 25	-53.23%
Aug 25	-43.68%
Jul 25	-35.21%
Jul 25	-42.06%
Jul 25	-33.55%
Jul 25	-26.88%
Jun 25	-26.6%
Jun 25	-27.95%
Jun 25	-28.16%
Jun 25	-26.04%
May 25	-25.27%
May 25	-25.53%
May 25	-29.53%
May 25	-32.54%
May 25	-34.6%
Apr 25	-20.71%
Apr 25	-15.77%
Apr 25	-15.38%
Apr 25	-16.62%
Mar 25	-15.24%
Mar 25	-15.36%
Mar 25	-15.16%
Mar 25	-15.71%
Feb 25	-15.32%
Feb 25	-14.88%
Feb 25	-16.72%
Feb 25	-15.03%
Jan 25	-12.47%
Jan 25	-6.56%
Jan 25	-6.18%
Jan 25	-5.82%
Jan 25	-5.84%
Dec 24	-5.58%
Dec 24	-5.87%
Dec 24	-6.38%
Dec 24	-5.74%
Nov 24	-5.48%
Nov 24	-5.54%
Nov 24	-5.54%
Nov 24	-4.91%
Nov 24	-5.1%
Oct 24	-2.93%

Price to Book

BVAXF Price to Book by year
Period	Price to Book
Oct 23	2.26
Oct 23	2.09
Oct 23	3.65
Oct 23	2.78
Sep 23	2.98
Sep 23	2.91
Sep 23	2.85
Sep 23	2.84
Sep 23	4.12
Aug 23	2.95
Aug 23	2.97
Aug 23	2.89
Aug 23	2.82
Jan 23	1.63
Jan 23	1.76
Jan 23	1.91
Jan 23	1.92
Dec 22	1.9
Dec 22	1.99
Dec 22	2.11
Dec 22	2.33
Dec 22	2.87
Nov 22	2.49
Nov 22	2.43
Nov 22	2.67
Nov 22	3.24
Oct 22	2.74
Oct 22	3.02
Oct 22	2.49
Oct 22	3.23
Sep 22	1.76
Sep 22	1.48
Sep 22	1.56
Sep 22	1.74
Sep 22	1.62
Aug 22	1.58
Aug 22	1.75
Aug 22	1.75
Aug 22	1.97
Jul 22	1.93
Jul 22	2.23
Jul 22	2.08
Jul 22	2.33
Jul 22	1.41
Jun 22	1.18
Jun 22	1.26
Jun 22	1.61
Jun 22	1.51
May 22	1.8
May 22	1.65
May 22	1.33
May 22	1.66
Apr 22	1.51
Apr 22	1.52
Apr 22	1.47
Apr 22	1.72
Apr 22	1.54
Mar 22	1.7
Mar 22	1.62
Mar 22	1.39
Mar 22	1.77
Feb 22	1.92
Feb 22	2.05
Feb 22	2.04
Feb 22	1.96
Jan 22	1.5
Jan 22	1.68
Jan 22	1.95
Jan 22	1.83
Dec 21	1.77
Dec 21	1.94
Dec 21	1.93
Dec 21	2.24
Dec 21	2.15
Nov 21	2.82
Nov 21	2.29
Nov 21	2.97
Nov 21	3.29
Oct 21	3.27
Oct 21	3.63
Oct 21	3.39
Oct 21	4.03
Oct 21	4.13
Sep 21	4.72
Sep 21	5.12
Sep 21	3.6
Sep 21	3.02
Aug 21	2.08
Aug 21	2.1
Aug 21	2.13
Aug 21	2.18
Jul 21	2.18
Jul 21	2.09
Jul 21	2.08
Jul 21	2.39
Jul 21	2.65
Jun 21	2.15
Jun 21	2.11
Jun 21	2.32
Jun 21	1.99

No video analysis for this stock yet. Request one from our team.

News: BVAXF

newsfilecorp.com · 8 Sep 2026

BioVaxys Technology Corp. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

Vancouver, British Columbia--(Newsfile Corp. - September 8, 2026) - BioVaxys Technology Corp. (OTC Pink: BVAXF) (CSE: BIOV) (FSE: 5LB), ("BioVaxys" or the "Company") a clinical-stage biopharmaceutical company focused on the development of durable, single-dose, vaccines for safe, scalable, and long-lasting immune protection in oncology, infectious disease, and immune dysfunctions, is pleased to announce its participation at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, taking place September 9-10, 2026, in New York City. James Passin, Chief Executive Officer, will be attending the conference, delivering an investor presentation and participating in scheduled 1-on-1 meetings with investors.

AI Analysis

BioVaxys Technology Corp.

Video analysis: BVAXF

News: BVAXF

BioVaxys Technology Corp. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

Similar companies